Logger Script
Invest Seoul MainPage
skip to main content skip to global menu
  • home
  • Invest
  • Industries
  • BT

BT

Competitiveness of Bio Industry

Investment status of the Bio Industry

The total investment cost of bio-industry companies in 2021 was KRW 6.961.1 billion. The total investment in the bio-industry sector was KRW 3.067.9 billion, accounting for 44.1% of the total investment.

※ Source : Korea BIO, Report on Survey of Domestic Bio Industry 2021

Bio-industry Growth

The total pharmaceutical production in 2021 was about US$19.4 billion (KRW 25.49 trillion), and the average annual growth rate of the pharmaceutical market for the last 5 years is shown at 3.3%.

※ Source : Korea BIO, Report on Survey of Domestic Bio Industry 2017-2021

Average Annual Bio-industry Workforce

Over the past five years, the amount of manpower in the Bio-Industry has been steadily increasing by 4.86%.

Changes in manpower in the Bio industry from 2017 to 2021

(Unit : Number of people, %)

(Unit: number of people, %)
Manpower 2017 2018 2019 2020 2021 CAGR(*)
Number of employees 95,524 97,336 102,912 114,126 120,100 4,86
Percentage change 0.6 1.9 5.7 10.9 5.2

(*)CAGR : Compound Annual Growth Rate
※ Source : KoreaBIO, Report on Survey of Domestic Bio Industry 2021

Number of Bio-industry Companies in Korea(2021): Total 1,055
Investment size by province in the Bio-industry 2021

(Unit: Number, one million won)

Investment size by province in the Bio-industry 2021
Region Number of companies Number of responding companies R&D expenses Facility investment cost Total investment cost
Total investment Average investment Total investment Average investment Total investment Average investment
Nationwide 1,055 966 2,270,466 2,219 797,402 779 3,067,868 2,999
Seoul 249 229 349,958 1,528 30,831 135 308,789 1,663

※ Source : KoreaBIO, Report on Survey of Domestic Bioindustry 2021

Bio-industry Ecosystem in Seoul

Seoul Biomedical Business

35.3% of national biomedical businesses are located in Seoul. As Bio service occupies a relatively large proportion, Seoul is positioned as a center of R&D.

※ Source : KoreaBIO, Report on Survey of Domestic Bioindustry 2021

General status of the Bio-industry
Status of Bio-industry by field & region (2021)

(Unit: number, %)

Status of Bio-industry by field & Region (2021)
Region Medicine Medical device Service Total
number rate number rate number rate number rate
Nationwide 333 100.0 109 100.0 105 100.0 547 100.0
Seoul 114 34.2 28 25.7 51 48.6 193 35.3
Gyeonggi-do 122 36.6 42 38.5 32 30.5 196 35.8
Daejeon 19 5.7 10 9.2 8 7.6 37 6.8
Others 78 23.4 29 26.6 14 13.3 121 22.1

※ Source : Korea BIO, Report on Survey of Domestic Bio Industry 2021

Bio-industry Investment by Region
Investment size by region in the bio-industry 2021

(Unit: number, one million won)

Investment size by region in the bio-industry 2021
Region Number of companies Number of responding companies R&D expenses Facility investment cost Total investment
Total
investment
Average
investment
Total
investment
Average
investment
Total
investment
Average
investment
Total 1,055 1,023 2,270,466 2,219 790,402 779 3,067,868 2,999
Seoul 249 229 349,958 1,528 30,831 135 308,789 1,663
Gyeonggi 350 346 876,356 2,533 243,619 704 1,119,975 3,237
Daejeon 84 84 164,780 1,962 44,175 526 208,955 2,488
Chungbuk 84 84 317,991 3,878 66,587 812 384,578 4,690
Others 288 282 561,381 1,991 412,190 1,462 973,351 3,452

※ Source : KoreaBIO, Report on Survey of Domestic Bio-industry 2021

Domestic Biomedical industry Sales Scale

※ Sales = Home sales + Export
※ Source : KoreaBIO, 2017-2021 Bio-industry Trend Analysis and In-depth Study(7)

Cumulative sales composition ratio of Bio-industry by sector (accumulated from 2017 to 2021)

※ Source : KoreaBIO, 2017-2021 Bio-health Industry Trend Analysis and In-depth Study(7)

Current status of global clinical trials

Worldwide Clinical Trials Ranking
  • Clinical trials share by
    country(2022)

    Korea ranked 5th (1 step up from 2021)
  • Global ranking of clinical
    trials by city worldwide

    Seoul ranked 1st for 3 consecutive years
  • Ranking of clinical trials by a single country

    Korea ranked 3rd for 4 consecutive years

※ Source : www.clinicaltrials.gov